By Deena Beasley May 5 (Reuters) - Use of Gilead Sciences' Yeztugo, a twice-yearly injection to prevent HIV infection, has ...

A California court holds a pharmaceutical company can be found liable for not innovating quickly enough.

As part of a years-long effort by PrEP4ALL and other HIV groups to get Gilead Sciences, a pharmaceutical company, to lower ...

Gilead Sciences' twice-yearly HIV prevention injection Yeztugo has gained users since its June launch, but adoption is slowed by insurance coverage gaps, patient preference for pills, and concerns ...

Detailed price information for Botanix Pharmaceuticals (BXPHF) from The Globe and Mail including charting and trades.

Michael Chancley Jr.’s personal experience with PrEP informs his work at PrEP4All as he advocates for expanded access and ...